Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The study is a prospective, randomized, double-blind, placebo-controlled drug study to
evaluate the pattern of erectile function recovery after robotic assisted laparoscopic
prostatectomy (RALP). We hope to illustrate that early and continuous therapy with either
Sildenafil citrate or pentoxyfylline after nerve sparing RALP will promote improved erectile
function.